Pennsylvania: Allegheny General to Lead Genetic Study of Papilloma VirusJune 3, 2003 This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document. Dr. Farrel Buchinsky of Allegheny General Hospital in
Pittsburgh is leading a five-year study of genetic links to the
STD human papilloma virus. More than 50 million people in the
United States are infected with the virus, according to CDC.
Buchinsky's study focuses on recurrent respiratory
papillomatosis, which can be passed to an unborn child during
delivery and causes wart growth on the larynx and possibly in the
trachea and lungs. Buchinsky said he hopes the study's findings
lead to better treatment and possibly a cure. About 400 patients
and their parents are being recruited from hospitals. The
National Institutes of Health provided a $1 million grant for the
study.
Back to other CDC news for June 3, 2003 This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document. Associated Press 06.02.03 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|